ⓘ Letolizumab

                                     

ⓘ Letolizumab

Letolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.

This drug developed by Bristol-Myers Squibb.

                                     
  • humanized CCR5 breast cancer, HIV Lesofavumab mab human hemagglutinin HA Letolizumab scFv humanized TRAP inflammatory diseases Lexatumumab mab human TRAIL - R2